Oppenheimer analyst Michelle Gilson, reiterated her Outperform rating on shares of Cellectis (NASDAQ: CLLS) after the company Cellectis reported 2Q16 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE